Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Community
/
Ideas
/
LLY rides its success against obesity and diabetes LONG
Eli Lilly and Company
Long
LLY rides its success against obesity and diabetes LONG
By AwesomeAvani
Follow
Follow
Updated
Feb 25
1
Cheer
Cheer
1
1
Feb 25
LLY shown on a daily chart has doubled in the past year with the introduction of new FDA
approved drugs into the market. It has but out a series of favorable earnings reports with
optimistic realistic guidance and glowing analysts' forecasts. It has done so without any volume
pumps and just keeps grinding higher. This is because it is in the shadows of big technology
stocks. Revenues consistently beat analysts' forecasts quarter after quarter.
Institutions add small lots trying to preserve the price for future buys without any
run-ups. I have done the same thing and I will continue to do so. While day trading
biotechnology penny stocks, LLY along with UNH, PFE, and AZN is where the profits are
parked for growth and compounding.
Feb 25
Comment
Zoom-in shows buys at HLs and a sell at a HH since earnings-
AZN
bigpharma
diabetesmed
Earnings
lilly
LLY
obesity
Oscillators
PFE
pharmastocks
Trend Lines
UNH
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.